Stock AEON AEON BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company AEON Biopharma, Inc. Nasdaq

Equities

AEON

US00775E1029

Biotechnology & Medical Research

Business Summary

AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by inhibiting the release of acetylcholine into the neuromuscular junction, causing a flaccid paralysis of muscles. The active biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a complete molecular complex weight of 900 kDa. Its initial development programs for ABP-450 are directed at migraine, cervical dystonia, gastroparesis and post-traumatic stress disorder (PTSD). The Company has completed a Phase II study of ABP-450 for the treatment of cervical dystonia and are conducting a Phase II study of ABP-450 for the treatment of both chronic and episodic migraine.

Number of employees: 10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,788,858 22,223,136 ( 58.81 %) 0 58.81 %

Shareholders

NameEquities%Valuation
Vikram Malik
18.81 %
6,989,163 18.81 % 81 M $
Priveterra Sponsor LLC
18.57 %
6,900,000 18.57 % 80 M $
DAEWOONG CO., LTD.
17.70 %
6,577,604 17.70 % 76 M $
Polar Asset Management Partners, Inc.
10.43 %
3,875,000 10.43 % 45 M $
Atalaya Capital Management LP
9.890 %
3,675,000 9.890 % 43 M $
STRATHSPEY CROWN HOLDINGS GROUP, LLC
5.468 %
2,031,773 5.468 % 24 M $
Ikarian Capital LLC
0.6942 %
257,977 0.6942 % 3 M $
BlackRock Institutional Trust Co. NA
0.6517 %
242,165 0.6517 % 3 M $
Vanguard Global Advisers LLC
0.5646 %
209,785 0.5646 % 2 M $
Geode Capital Management LLC
0.4635 %
172,246 0.4635 % 2 M $
NameEquities%Valuation
Shaolin Capital Management LLC
-
917,120 - 1 M $
Cantor Fitzgerald & Co.
-
596,666 - 865 166 $
Davidson Kempner Capital Management LP
-
366,671 - 531 673 $
Aristeia Capital LLC
-
358,333 - 519 583 $
LMR Partners LLP
-
249,999 - 362 499 $
Cowen & Co. LLC
-
231,860 - 336 197 $
Tenor Capital Management Co. LP
-
166,666 - 241 666 $
D.E. Shaw & Co., Inc.
-
154,432 - 223 926 $
Periscope Capital, Inc.
-
150,000 - 217 500 $
Radcliffe Capital Management LP
-
139,840 - 202 768 $

Company contact information

AEON Biopharma, Inc.

5 Park Plaza Suite 1750

92614, Irvine

+

http://www.aeonbiopharma.com
address AEON Biopharma, Inc.(AEON)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.51% 104B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+3.22% 97.42B
ARGENX SE Stock argenx SE
+1.86% 22.2B
BIONTECH SE Stock BioNTech SE
-16.53% 21.23B
GENMAB A/S Stock Genmab A/S
-8.49% 18.33B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-42.33% 16.35B
BEIGENE, LTD. Stock BeiGene, Ltd.
-20.09% 15.06B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.47% 13.98B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+28.85% 11.66B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. AEON Stock
  4. AEON Stock
  5. Company AEON Biopharma, Inc.